http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health to Accelerate Innovative Phase III Study in Patients with Atrial Fibrillation
-
Syneos Health Partners with Science 37® to Transform Clinical Trials – Increasing Speed and Diversity
-
Amulet Capital Partners Completes the Sale of Synteract to Syneos Health
-
Syneos Health Completes Acquisition of Synteract
-
Amulet Capital Backed Synteract To Be Acquired by Syneos Health
-
Syneos Health, Inc. (SYNH) to Acquire Synteract
-
Syneos Health to Acquire Synteract, a Top CRO Provider to Emerging Biopharma
-
Acerus Announces Addition of US Commercial Leader
-
Syneos Health Strengthens Commercial Services With Veeva Commercial Cloud
-
Syneos Health Strengthens Commercial Services with Veeva Commercial Cloud
-
AiCure's strategy of providing data for life sciences reinforced by record economic momentum
-
Expanded U.S. NATETSO® Partnership Between Acerus Pharmaceuticals and Aytu BioScience Is Now Fully Operational
-
Acerus and Aytu Bioscience to Co-promote Natesto® in the United States
-
Acerus And Aytu Bioscience To Co-Promote NATESTO® In The United States
-
Syneos Health to Share Critical Insights for Maximizing Value and Fueling Commercial Success at Biotech Showcase Events
-
Syneos Health Releases the 2019 Health Trend Ten, Outlining Critical Shifts Impacting Drug Development and Commercialization
-
Syneos Health to Share Strategies Designed to Meet the Needs of Patients, Payers and Regulators at DIA Global Annual Meeting
-
Syneos Health to Present Actionable Commercial Insights Designed for Biopharmaceutical Companies at BIO International Convention